T1	HMM 454 513	safety, tolerability, pharmacokinetics and pharmacodynamics
T2	HMM 787 819	well-absorbed and well-tolerated
T3	HMM 847 887	Minimal treatment-related adverse events
T4	HMM 919 944	Serum interferon (IFN)-Î±
T5	HMM 1230 1232	h.
T6	HMM 1233 1291	Induction of chemokines/cytokines and IFN-stimulated genes
T7	HMM 1427 1475	demonstrates safety and pharmacodynamic activity
